Corvus Pharmaceuticals Inc Net Asset Quality Index
Corvus Pharmaceuticals Inc net asset quality index. Corvus Pharmaceuticals Inc (CRVS) has a Net Asset Quality Index of 94.2% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $239.27 Million minus total liabilities of $13.95 Million yields net assets of $225.33 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Corvus Pharmaceuticals Inc (CRVS) net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Corvus Pharmaceuticals Inc (2014–2025)
Net asset quality index of Corvus Pharmaceuticals Inc from 2014 to 2025. This chart shows how Corvus Pharmaceuticals Inc's Net Asset Quality Index has evolved across 12 annual periods from 2014 to 2025. As of June 2026, the index stands at 94.2%, representing net assets of $225.33 Million against total assets of $239.27 Million USD. Check asset allocation strategy of Corvus Pharmaceuticals Inc to assess the company's strategic physical and investment asset allocation.
Corvus Pharmaceuticals Inc Net Asset Quality Index by Year (2014–2025)
Corvus Pharmaceuticals Inc net asset quality index by year from 2014 to 2025. The table below presents the year-by-year Net Asset Quality Index for Corvus Pharmaceuticals Inc from 2014 to 2025, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Corvus Pharmaceuticals Inc market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 86.1% | $61.20 Million | $71.12 Million | $9.91 Million | ▲ +38.8 pp |
| 2024 | 47.3% | $32.57 Million | $68.91 Million | $36.34 Million | ▼ -37.7 pp |
| 2023 | 84.9% | $38.68 Million | $45.55 Million | $6.87 Million | ▲ +2.7 pp |
| 2022 | 82.2% | $56.12 Million | $68.24 Million | $12.12 Million | ▼ -6.5 pp |
| 2021 | 88.8% | $97.16 Million | $109.45 Million | $12.29 Million | ▲ +4.4 pp |
| 2020 | 84.4% | $72.15 Million | $85.53 Million | $13.38 Million | ▼ -0.7 pp |
| 2019 | 85.0% | $71.11 Million | $83.65 Million | $12.54 Million | ▼ -8.3 pp |
| 2018 | 93.3% | $110.34 Million | $118.23 Million | $7.90 Million | ▲ +3.8 pp |
| 2017 | 89.5% | $84.83 Million | $94.78 Million | $9.94 Million | ▼ -5.2 pp |
| 2016 | 94.8% | $132.80 Million | $140.15 Million | $7.35 Million | ▲ +126.3 pp |
| 2015 | -31.6% | $-31.10 Million | $98.46 Million | $129.56 Million | ▼ -30.3 pp |
| 2014 | -1.3% | $-159.00K | $12.53 Million | $12.69 Million | — |